Nautilus Biotechnology, Inc.

NAUT

Exchange: Nasdaq
Industry: Laboratory Analytical Instruments
SEC CIK: 0001808805

SEC filings (opens in a new tab)

No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Nautilus Biotechnology, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of NAUT: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	81	1	93	+13
Shares	54.3M	29	50.1M	−4.20M (−7.7%)
Value	$210.8M	$113	$93.7M	−$117.1M (−55.6%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Nautilus Biotechnology, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to NAUT in Q2 2026
Institution	Shares	Value	% of portfolio
Citadel Advisors LLC	1,896,192	$3.55M	0.00%
Susquehanna International Group, LLP	890,949	$1.67M	0.00%
JPMorgan Chase & Co	614,177	$1.10M	0.00%
Vanguard Portfolio Management LLC	337,748	$631.6K	0.00%
Charles Schwab Investment Management Inc	123,684	$231.3K	0.00%
Bank of New York Mellon Corp	122,570	$229.2K	0.00%
Nuveen, LLC	66,202	$123.8K	0.00%
Quadrature Capital Ltd	58,559	$109.5K	0.00%
Y-Intercept (Hong Kong) Ltd	58,152	$108.7K	0.00%
American Century Companies Inc	52,689	$98.5K	0.00%
Virtu Financial LLC	49,943	$93.0K	0.00%
Deutsche Bank AG	48,518	$90.7K	0.00%
Price T Rowe Associates Inc	40,760	$77.0K	0.00%
Rhumbline Advisers	36,567	$68.4K	0.00%
Invesco Ltd.	35,200	$65.8K	0.00%
Axq Capital, LP	34,147	$63.9K	0.01%
Squarepoint Ops LLC	33,746	$63.1K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	22,898	$42.8K	0.00%
Police & Firemen's Retirement System of New Jersey	18,983	$35.5K	0.00%
New York State Common Retirement Fund	14,000	$26.2K	0.00%
Balyasny Asset Management LLC	13,184	$24.7K	0.00%
Intech Investment Management LLC	11,857	$22.2K	0.00%
Group One Trading, L.P.	8,197	$15.3K	0.00%
Legal & General Group Plc	4,844	$9.06K	0.00%
Ameritas Investment Partners, Inc.	4,513	$8.44K	0.00%
Russell Investments Group, Ltd.	3,976	$7.43K	0.00%
Tower Research Capital LLC (TRC)	2,827	$5.29K	0.00%
Simplex Trading, LLC	1,090	$2.04K	0.00%
Sterling Capital Management LLC	922	$1.72K	0.00%
Allworth Financial LP	72	$135	0.00%

Sold out (17)

Institutions that held Nautilus Biotechnology, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of NAUT in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Amazon.com, Inc.	1,457,055	$5.65M
Tikvah Management LLC	726,895	$2.82M
Crown Advisors Management, Inc.	100,000	$388.0K
Jane Street Group, LLC	61,802	$239.8K
Brevan Howard Capital Management LP	60,501	$234.7K
Jacobs Levy Equity Management, Inc	46,394	$180.0K
Polen Capital Management LLC	40,345	$156.5K
Hudson Bay Capital Management LP	29,594	$114.8K
Omers Administration Corp	24,500	$95.1K
Diametric Capital, LP	22,806	$88.5K
Public Employees Retirement System of Ohio	19,300	$74.9K
CTC Alternative Strategies, Ltd.	12,397	$48.1K
Schonfeld Strategic Advisors LLC	12,010	$46.6K
Nine Masts Capital Ltd	10,395	$40.3K
National Bank of Canada	300	$1.16K
Your Advocates Ltd., LLP	150	$582
EverSource Wealth Advisors, LLC	18	$70

Not filed for Q2 2026 yet (1)

Institutions that held Nautilus Biotechnology, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NAUT in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	29	$113